Atlas Trials

Open-Label, Safety and Superior Effectiveness Study of Cysteamine Bitartrate Delayed-Release Capsules (RP103) in Cystinosis

Clinical trial NCT01733316 · COMPLETED

Trial details

NCT number
NCT01733316
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Cystinosis
Start date
2013-01-31
Primary completion
2015-02-01
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.